Healthcare Research
Royalty Pharma Reports Second Quarter 2020 Results Nasdaq:RPRX
Strong double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Receipts(1) (non-GAAP) Company introduces 2020 guidance: Adjusted...
Aquestive Therapeutics: Remains On The Track After Q2 Results (NASDAQ:AQST)
Overview Aquestive Therapeutics (NASDAQ:AQST) has posted Q2 results beating the street by $0.36 in EPS and $12.91 million in revenues,...
Daily Mirror – Inauguration of SLIM ‘License to Sell’ for 2020
Mr. Sanath Senanayake – CEO/ED SLIM, Dr. Pradeep Edward Past President and Advisor...
Jesus Rodriguez: 10 Reasons Why Quant Strategies for Crypto Fail | Fintech Zoom
Jesus Rodriguez is the CEO of IntoTheBlock, a market intelligence platform for crypto assets. He’s held leadership roles in major...
The Proliferation Of Individual Condiments Packages In The Coronavirus Era NK#128196
PRN | 23 days ago CLEVELAND: Single-use condiments are making a resurgence. In the packaging world, that means we're...
Edited Transcript of GDP.A earnings conference call or presentation 11-Aug-20 3:00pm GMT
HOUSTON Aug 11, 2020 (Thomson StreetEvents) -- Edited Transcript of Goodrich Petroleum Corp earnings conference call or presentation Tuesday, August...
Investors Flock to AI-based Drug Discovery
The application of convolutional neural network technology continues to expand beyond machine vision use cases to the red-hot drug discovery...
AGCPN to host dialogue for health professionals, others
The Association for Good Clinical Practice in Nigeria (AGCPN) has announced it is hosting physicians, health professionals, researchers and bio-entrepreneurs...
Inauguration of SLIM ‘License to Sell’ for 2020 – Adaderana Biz English
The inauguration ceremony of SLIMs ‘License to Sell’ (LTS) 2020 batch 6 was held on 8th July at SBS, Colombo....
Globus Medical Climbs 18.12% From Q2 Exit – Beats EPS By $0.18; But Let’s Not Jump In Just Yet (NYSE:GMED)
Overview The medical device company Globus Medical (NYSE:GMED) has beaten The Street's Q2 EPS estimates, scoring a surprise of $0.07...
